HP INC — Director's Dealing 2015

Nov 13, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HP INC (HPQ)
CIK: 0000047217
Period of Report: 2015-11-01

Reporting Person: LORES ENRIQUE (President, PSS)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	.562	Direct
Common Stock	980	Indirect
Common Stock	3165	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$48.45	2016-04-21	Common Stock (20000)		Direct
Employee Stock Option (right to buy)	$13.83	2020-12-06	Common Stock (45000)		Direct
Employee Stock Option (right to buy)	$26.99	2021-12-11	Common Stock (25000)		Direct
Employee Stock Option (right to buy)	$37.36	2022-12-10	Common Stock (30000)		Direct
Employee Stock Option (right to buy)	$26.96	2023-10-30	Common Stock (217822)		Direct
Restricted Stock Units	$		Common Stock (6978.8919)		Direct
Restricted Stock Units	$		Common Stock (4333.1832)		Direct
Restricted Stock Units	$		Common Stock (6807.8919)		Direct
Restricted Stock Units	$		Common Stock (153202.1323)		Direct
Restricted Stock Units	$		Common Stock (64911)		Direct

Footnotes

F1: This option became exercisable beginning on this date.

F2: This option will become exercisable in three equal annual installments beginning on this date.

F3: This option is no longer exercisable beginning on this date.

F4: The performance contingent stock options will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date.

F5: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F6: On 07/29/15 the Issuer announced approved amendments to certain outstanding long-term incentive awards that were originally scheduled to vest between 09/18/15 and 12/31/15, to provide for the accelerated vesting on 09/17/15.

F7: On 07/26/13 the reporting person was granted 20,000 restricted stock units ("RSUs"), 6,666 of which vested on 07/26/14, 6,667 of which vested on 07/26/15, and 6,667 of which will vest on 07/26/16. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on the Issuer's common stock. The number of derivative securities in column 5 includes 311.8919 vested dividend equivalent rights accrued but not released since the grant date.

F8: On 12/11/13 the reporting person was granted 12,500 RSUs, 4,166 of which vested on 12/11/14, 4,167 of which vested early on 09/17/15, and 4,167 of which will vest on 12/11/16. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on the Issuer's common stock. The number of derivative securities in column 5 includes 166.1832 vested dividend equivalent rights accrued but not released since the grant date.

F9: On 12/10/14 the reporting person was granted 10,000 RSUs, 3,333 of which vested early on 09/17/15, 3,333 of which will vest on 12/10/16, and 3,334 of which will vest on 12/10/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on the Issuer's common stock. The number of derivative securities in column 5 includes 140.8919 vested dividend equivalent rights accrued but not released since the grant date.

F10: On 03/18/15 the reporting person was granted 151,378 RSUs, 50,459 of which will vest on each of 03/18/16 and 03/18/17, and 50,460 of which will vest on 03/18/18. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on the Issuer's common stock. The number of derivative securities in column 5 includes 1,824.132 vested dividend equivalent rights accrued but not released since the grant date.

F11: On 10/30/15 the reporting person was granted 64,911 RSUs, 21,637 of which will vest on each of 10/30/16, 10/30/17, and 10/30/18. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on the Issuer's common stock.